To identify PIK3CA mutation-related genes, microarray analysis (Affymetrix U133 Plus 2.0 arrays) was first applied to 43 ERα-positive breast tumors, of which 14 were PIK3CA-mutated and 29 were wild-type (Table S1). The gene discussed is ESR1; the disease is breast neoplasm.